# Noninvasively Predicting Gene Status of Glioma

> **NCT03102112** · — · UNKNOWN · sponsor: **Tang-Du Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Glioma of Brain

## Interventions

- **OTHER:** MRI examination

## Key facts

- **NCT ID:** NCT03102112
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2017-04-10
- **Final completion:** 2018-03-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03102112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03102112, "Noninvasively Predicting Gene Status of Glioma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03102112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*